CSIMarket
 

Therapeutic Solutions International Inc   (TSOI)

Therapeutic Solutions International Inc 's

Competitiveness




 

TSOI Sales vs. its Competitors Q3 2024



Comparing the current results to its competitors, Therapeutic Solutions International Inc reported Revenue decrease in the 3 quarter 2024 year on year by -23.47 %, faster than the overall decrease of Therapeutic Solutions International Inc 's competitors by 0 %, recorded in the same quarter.

List of TSOI Competitors





Revenue Growth Comparisons




Net Income Comparison


Therapeutic Solutions International Inc recorded a net loss, as well as most of its competitors.

<<  TSOI Stock Performance Comparisons



*Market share is calculated based on total revenue.





Publicly Traded Peers of Therapeutic Solutions International Inc




Arch Therapeutics Inc
Share Performance



-7.19%
30 Days



Arch Therapeutics Inc
Profile

Arch Therapeutics Inc's business model focuses on the development and commercialization of novel self-assembling peptide-based technologies for use in the healthcare industry.

More about Arch Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.889 mill. $ 0.148 mill. $ -12.263 mill.


Vycor Medical Inc
Share Performance



-1.49%
Over The Past 5 Days



Vycor Medical Inc
Profile

Vycor Medical Inc has a business model focused on developing and commercializing innovative medical devices and technologies in the healthcare industry.

More about Vycor Medical Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2.203 mill. $ 1.807 mill. $ -0.060 mill.


Mesoblast Limited
Share Performance



-14.98%
This Year



Mesoblast Limited
Profile

Mesoblast Ltd is a biotechnology company that operates on a business model focused on the development and commercialization of proprietary cell-based regenerative medicines. They aim to transform the treatment of various degenerative diseases by utilizing their patented technology and strategic partnerships with pharmaceutical companies.

More about Mesoblast Limited's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 17.198 mill. $ -102.142 mill.


Marizyme Inc
Share Performance



-0.77%
Over The Past 5 Days



Marizyme Inc
Profile

Marizyme Inc operates on a business model that focuses on developing and commercializing innovative therapies derived from marine sources. The company utilizes enzymatic technologies to create effective and sustainable solutions for various medical applications and is committed to improving patient outcomes by advancing the development of novel therapeutics. Marizyme aims to establish partnerships and collaborations with healthcare organizations and pharmaceutical companies to bring its products to market efficiently and effectively.

More about Marizyme Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,871.705 mill. $ - mill. $ -26.217 mill.


Insight Molecular Diagnostics Inc
Share Performance



-9.33%
30 Days



Insight Molecular Diagnostics Inc
Profile

The company develops molecular diagnostic test kits for detecting transplanted organ rejection.

More about Insight Molecular Diagnostics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 149.940 mill. $ 1.670 mill. $ -49.359 mill.

5 more competitors available

Sign in to see all competitors

Sources: Therapeutic Solutions International Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Therapeutic Solutions International Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.